Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

被引：0
|
作者：
Cindy L. J. Weinstein
Alan G. Meehan
Jianxin Lin
Steven D. Briscoe
Marinella Govoni
机构：
[1] Merck & Co.,
[2] Inc,undefined
[3] MSD Italy,undefined
来源：
Clinical Rheumatology | 2023年 / 42卷
关键词：
Golimumab; TNF-α; Treatment persistence; Rheumatoid arthritis; Psoriatic arthritis; Ankylosing spondylitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3397 / 3405
页数：8
相关论文
共 50 条
  • [1] Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    Weinstein, Cindy L. J.
    Meehan, Alan G.
    Lin, Jianxin
    Briscoe, Steven D.
    Govoni, Marinella
    CLINICAL RHEUMATOLOGY, 2023, 42 (12) : 3397 - 3405
  • [2] Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry
    Manara, M.
    Caporali, R.
    Favalli, E. G.
    Grosso, V.
    Atzeni, F.
    Sarzi-Puttini, P.
    Gorla, R.
    Bazzani, C.
    Fusaro, E.
    Pellerito, R.
    Rocchetta, P. A.
    Sinigaglia, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (05) : 804 - 809
  • [3] Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    M. Elaine Husni
    Atul Deodhar
    Sergio Schwartzman
    Soumya D. Chakravarty
    Elizabeth C. Hsia
    Jocelyn H. Leu
    Yiying Zhou
    Kim H. Lo
    Arthur Kavanaugh
    Arthritis Research & Therapy, 24
  • [4] Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    Husni, M. Elaine
    Deodhar, Atul
    Schwartzman, Sergio
    Chakravarty, Soumya D.
    Hsia, Elizabeth C.
    Leu, Jocelyn H.
    Zhou, Yiying
    Lo, Kim H.
    Kavanaugh, Arthur
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [5] Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis
    Pombo-Suarez, Manuel
    Seoane-Mato, Daniel
    Diaz-Gonzalez, Federico
    Cea-Calvo, Luis
    Sanchez-Alonso, Fernando
    Sanchez-Jareno, Marta
    Jovani, Vega
    Garcia-Magallon, Blanca
    Martinez-Gonzalez, Olga
    Campos-Fernandez, Cristina
    Manero, Javier
    Diaz-Torne, Cesar
    Bohorquez, Cristina
    Ros-Vilamajo, Inmaculada
    Perez-Vera, Yanira
    Castrejon, Isabel
    MUSCULOSKELETAL CARE, 2023, 21 (01) : 189 - 197
  • [6] High 3-year golimumab survival in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: real world data from 328 patients
    Thomas, K.
    Flouri, I
    Repa, A.
    Fragiadak, K.
    Sfikakis, P. P.
    Koutsianas, C.
    Kaltsonoudis, E.
    Voulgari, P. V.
    Drosos, A. A.
    Petrikkou, E.
    Sidiropoulos, P.
    Vassilopoulos, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (02) : 254 - 262
  • [7] Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry
    Pombo-Suarez, Manuel
    Sanchez-Piedra, Carlos
    Garcia-Magallon, Blanca
    Perez-Gomez, Ana
    Manrique-Arija, Sara
    Martin-Domenech, Raquel
    Colazo, Maria
    Campos, Cristina
    Campos, Jose
    del Pino-Montes, Javier
    Arteaga, Maria J.
    Cea-Calvo, Luis
    Diaz-Gonzalez, Federico
    Gomez-Reino, Juan J.
    CLINICAL RHEUMATOLOGY, 2021, 40 (10) : 3979 - 3988
  • [8] Long-Term Retention Rate of Golimumab in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis in a Real-Life Setting
    Serrano-Benavente, Belen
    Valor, Larissa
    del Rio Blasco, Tamara
    Janta, Iustina
    Gonzalez Benitez, Roberto
    Nieto-Gonzalez, Juan Carlos
    Martinez-Barrio, Julia
    Ovalles Bonilla, Juan Gabriel
    Ariza, Alfonso
    Lopez-Longo, Francisco Javier
    Alvaro-Gracia, Jose Maria
    Monteagudo, Indalecio
    Gonzalez-Fernandez, Carlos Manuel
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (01) : E150 - E155
  • [9] Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry
    Manuel Pombo-Suarez
    Carlos Sanchez-Piedra
    Blanca Garcia-Magallón
    Ana Pérez-Gómez
    Sara Manrique-Arija
    Raquel Martín-Doménech
    María Colazo
    Cristina Campos
    José Campos
    Javier del Pino-Montes
    Maria J. Arteaga
    Luis Cea-Calvo
    Federico Díaz-González
    Juan J. Gómez-Reino
    Clinical Rheumatology, 2021, 40 : 3979 - 3988
  • [10] Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data
    Gottlieb, Alice B.
    Deodhar, Atul
    Mcinnes, Iain B.
    Baraliakos, Xenofon
    Reich, Kristian
    Schreiber, Stefan
    Bao, Weibin
    Marfo, Kwaku
    Richards, Hanno B.
    Pricop, Luminita
    Shete, Abhijit
    Trivedi, Vivek
    Keefe, Deborah
    Papavassilis, Charis C.
    Jagiello, Piotr
    Papanastasiou, Philemon
    Mease, Philip J.
    Lebwohl, Mark
    ACTA DERMATO-VENEREOLOGICA, 2022, 102
12345